← Back to dashboard
ISRG Robotics & Physical AI Surgical robotics leader Open in compare 3D performance Excel model

Intuitive Surgical

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Live metrics are partially unavailable

4 of 21 live fields are unavailable right now. The chart, thesis sections, and source links still make the page usable.

17 live 4 unavailable
Price $353.17 Live
1D Change +2.24% 1 day
Market Cap $125.08B Live
Enterprise Value $113.69B Current
Trailing P/E 40.6 TTM
Forward P/E 29.4 Forward
PEG Ratio 1.81x Yahoo est.
Price / Sales 11.3 TTM
EV / Revenue 10.3 TTM
Revenue Growth 18.5% YoY latest qtr
Earnings Growth 26.5% YoY latest qtr
Gross Margin 66.8% TTM
Operating Margin 33.7% TTM
Net Margin 28.4% TTM
ROE 17.4% TTM
Free Cash Flow TTM
FCF Margin TTM
Debt / Equity Latest qtr
Current Ratio 6.43x Latest qtr
Dividend Yield 0.00% Annualized
Next Earnings Calendar

Metric timing

This page mixes live market data, trailing fundamentals, and latest reported statement data.

Live / market snapshot

Price, 1D change, market cap, and enterprise value are current market-based figures.

TTM / forward

Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.

Latest quarter / dividend cadence

Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.

Revenue $10.06B Dec 31, 2025

latest annual revenue

Revenue $nan Jun 30, 2026

latest quarterly revenue

Net Income $2.86B Dec 31, 2025

latest annual profit

Net Income $nan Jun 30, 2026

latest quarterly profit

Dividend / Share $0.00 No regular dividend

annualized per share

Last Dividend No dividend history

latest ex-dividend cash amount

Price chart

Data loads live when the page opens.

Latest headlines

Recent company headlines. Each link opens the original article in a new tab.

Trefis Jul 20, 2026
The Robot Maker's Paradox

You can be forgiven for doing a double-take on Intuitive Surgical (ISRG) on Friday. The company posted second-quarter revenue of $2.89 billion, up 19% from a year ago and comfortably ahead of Wall Street estimates. Yet the stock ended the day down 14.1%, closing at a new 52-week low.

Trefis Jul 20, 2026
What's More Important For Intuitive Surgical: Today's Robots Or Tomorrow's Growth?

The surgical robotics giant beat estimates, but a moderation in its core US market has investors questioning the whole story.

Zacks Jul 20, 2026
3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Jul 20, 2026
Down 15% in 4 Weeks, Here's Why You Should You Buy the Dip in Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Jul 20, 2026
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Simply Wall St. Jul 20, 2026
US Stock Market Today: S&P 500 Futures Drop As Yields Ease And Housing Cools

The Morning Bull - US Market Morning Update Monday, Jul, 20 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down around 1%, as investors weigh falling bond yields against a cooling housing backdrop. The US 10 year Treasury yield has slipped to about 4.5% after softer inflation readings. In plain terms, this means borrowing costs in financial markets are easing a little even as the debate over the Federal Reserve's next move continues. At the same time,...

Why it could benefit going forward

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.

Business snapshot

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.